Qurient Therapeutics
Latest round
- Series B
Last raised
- Jun 2014
Total raised
- $22M
Investors
- 9
About Qurient Therapeutics
Based in Seongnam, South Korea, and established in 2008, Qurient Therapeutics operates as a clinical-stage biopharmaceutical company that develops novel therapeutics for oncology and inflammatory diseases.34 million shares in Qurient Therapeutics at KRW 5,952 apiece for KRW 8 billion, in a PIPE transaction.
Who invested in Qurient Therapeutics
9 investors across 2 rounds
See all investors in Qurient Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Qurient Therapeutics
Who invested in Qurient Therapeutics?
Qurient Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Qurient Therapeutics raised?
Qurient Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Qurient Therapeutics last raise money?
Qurient Therapeutics's most recent round on record is a Series B, in Jun 2014.
What does Qurient Therapeutics do?
Based in Seongnam, South Korea, and established in 2008, Qurient Therapeutics operates as a clinical-stage biopharmaceutical company that develops novel therapeutics for oncology and inflammatory diseases.
Where is Qurient Therapeutics headquartered?
Qurient Therapeutics is headquartered in Seongnam, South Korea.
Which VCs invest in companies like Qurient Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Qurient Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Qurient Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.